STOCK TITAN
  1. Home
  2. News
  3. TOIIW

Oncology Institute Inc (The) - TOIIW STOCK NEWS

Welcome to our dedicated news page for Oncology Institute (The) (Ticker: TOIIW), a resource for investors and traders seeking the latest updates and insights on Oncology Institute (The).

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Oncology Institute (The)'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Oncology Institute (The)'s position in the market.

News
The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call
Rhea-AI Summary
The Oncology Institute, (“TOI”) announces the release of its first quarter 2024 financial results on May 14, 2024, followed by a conference call at 5:00 p.m. (Eastern Time). Interested parties can access the live conference call and replay by phone or webcast. TOI is a leading value-based oncology group in the US.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.42%
Tags
earnings
-
News
Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute
Rhea-AI Summary
The Oncology Institute, Inc. (NASDAQ: TOI) appoints Jordan McInerney as the new Chief Development Officer, bringing over 15 years of healthcare leadership experience. McInerney will focus on growth initiatives, partnerships with payors, M&A processes, and establishing MSO platforms for value-based oncology care. His background includes executive roles at HOPCo Network Solutions and Stryker, emphasizing value-based care solutions and strategic partnerships.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.35%
Tags
management
-
News
The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California
Rhea-AI Summary
The Oncology Institute, Inc. (TOI) partners with Healthly to provide cancer care services in Southern California, starting July 1, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
none
News
The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024
Rhea-AI Summary
The Oncology Institute, Inc. (NASDAQ: TOI) reported financial results for Q4 2023, showing revenue growth, a capitated contract in South Florida, and an acquisition. Despite revenue growth, there was a decrease in gross profit and a net loss. TOI's CEO is optimistic about future success, with an outlook for 2024 projecting revenue of $400-415 million and adjusted EBITDA of $(8)-$(18) million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.13%
Tags
earnings
-
News
MaxHealth & The Oncology Institute Expand Value-Based Care Partnership
Rhea-AI Summary
The Oncology Institute, Inc. (NASDAQ: TOI) announces a new agreement with MaxHealth for clinical and financial accountability in 5 Florida Counties. TOI will take on full-risk responsibility for oncology care in Pinellas, Hillsborough, Polk, Broward, and Miami-Dade Counties, aligning with MaxHealth's value-based care model. The partnership aims to provide exceptional cancer care to patients through a focus on outcomes, quality, and community-based oncology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.62%
Tags
partnership
-
News
The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call
Rhea-AI Summary
The Oncology Institute (TOI) will release its Q4 and full year 2023 financial results on March 27, 2024. The conference call will be held at 5:00 p.m. (Eastern Time) on the same day. Investors can access the call via phone or webcast. Replay options are available until April 3, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.21%
Tags
earnings
News
The Oncology Institute to Participate at Upcoming Investor Conferences
Rhea-AI Summary
The Oncology Institute, Inc. (NASDAQ: TOI) announces Dr. Daniel Virnich's participation in upcoming investor conferences. Investors can join webcasts to hear insights at Cowen Annual Health Care Conference and Jefferies Value Based Healthcare Summit.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.14%
Tags
conferences
-
News
Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment Model
Rhea-AI Summary
The Oncology Institute (TOI) partners with Carrum Health to offer high-quality, cost-effective breast cancer care in Las Vegas, Nevada. The collaboration aims to provide comprehensive bundled packages for non-metastatic breast cancer patients through employers, expanding TOI's patient base and network access.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.08%
Tags
none
-
News
WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and Ohio
Rhea-AI Summary
WellBe Senior Medical strengthens its cancer care capabilities by partnering with The Oncology Institute, Inc. (NASDAQ: TOI) to offer High-Value Cancer Care Program to eligible patients in Illinois and Ohio. The program aims to provide personalized care management and supportive services to patients with active cancer diagnoses, resulting in improved patient satisfaction and reduced acute care facility utilization.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.15%
Tags
partnership
News
The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations in California
Rhea-AI Summary
The Oncology Institute, Inc. (TOI) has started operations of its first pharmacy in California after receiving approval from the California State Board of Pharmacy. This new service allows TOI to fill critical specialty medications and chemotherapeutics for MediCal patients, as well as provide medication fill capabilities to other patient populations. The new pharmacy location in the Los Angeles area aims to significantly expand TOI's oral drug business, addressing the cancer care costs of hundreds of thousands of MediCal patients. TOI has already lowered out-of-pocket costs for patients through its medically integrated dispensaries and expects to continue this trend with the new pharmacy location.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.61%
Tags
none
Stock TOIIW logo
Oncology Institute Inc (The)

Nasdaq:TOIIW

TOIIW Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

TOIIW Stock Data

32.81M
Offices of Physicians (except Mental Health Specialists)
Health Care and Social Assistance
Link
United States
Cerritos

About TOIIW

the oncology institute of hope and innovation is a premier cancer treatment center in los angeles. offering programs to help patients and families cope with the challenges that are brought on by cancer and strive to optimize their quality of life, comprehensive and realistic treatment goals are tailored to every person's unique needs and decided upon in partnership with the patients and their families. dedicated to excel in cancer prevention, diagnosis and education through our exceptional team of physicians, nurse practitioners, nurses, medical assistants and office staff, the oncology institute of hope and innovation has 8 southern california locations in the cities of downey, long beach, lynwood, montebello whittier, anaheim, la mirada and glendale. for more information please visit www.theoncologyinstitute.com.